Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Kraehenmann

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Neuropharmacology|June 20, 2017
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic ImplicationsRainer Kraehenmann
Current Topics in Behavioral Neurosciences|April 27, 2017
Experimental Psychosis Research and Schizophrenia-Similarities and Dissimilarities in PsychopathologyLeo Hermle, Rainer Kraehenmann
Frontiers in Human Neuroscience|July 13, 2018
Neuropsychodynamic Approach to Depression: Integrating Resting State Dysfunctions of the Brain and Disturbed Self-Related ProcessesHeinz Boeker, Rainer Kraehenmann
Plos One|October 11, 2012
Crowding deficits in the visual periphery of schizophrenia patientsRainer Kraehenmann, Franz X Vollenweider, Erich Seifritz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 15, 2016
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experienceThomas Pokorny, Katrin H Preller, Rainer Kraehenmann, et al.
Frontiers in Psychiatry|December 21, 2018
Early Linguistic Markers of Trauma-Specific Processing Predict Post-trauma AdjustmentBirgit Kleim, Andrea B Horn, Rainer Kraehenmann, et al.
Frontiers in Psychology|August 23, 2018
Too Imperfect to Fall Asleep: Perfectionism, Pre-sleep Counterfactual Processing, and InsomniaRalph E Schmidt, Delphine S Courvoisier, Stéphane Cullati, et al.
Human Brain Mapping|February 27, 2016
Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulationMilan Scheidegger, Anke Henning, Martin Walter, et al.
Neuroimage|July 17, 2017
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flowCandace R Lewis, Katrin H Preller, Rainer Kraehenmann, et al.
Neuroimage. Clinical|February 25, 2016
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivityRainer Kraehenmann, André Schmidt, Karl Friston, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Neuropharmacology|June 20, 2017
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic ImplicationsRainer Kraehenmann
Current Topics in Behavioral Neurosciences|April 27, 2017
Experimental Psychosis Research and Schizophrenia-Similarities and Dissimilarities in PsychopathologyLeo Hermle, Rainer Kraehenmann
Frontiers in Human Neuroscience|July 13, 2018
Neuropsychodynamic Approach to Depression: Integrating Resting State Dysfunctions of the Brain and Disturbed Self-Related ProcessesHeinz Boeker, Rainer Kraehenmann
Plos One|October 11, 2012
Crowding deficits in the visual periphery of schizophrenia patientsRainer Kraehenmann, Franz X Vollenweider, Erich Seifritz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 15, 2016
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experienceThomas Pokorny, Katrin H Preller, Rainer Kraehenmann, et al.
Frontiers in Psychiatry|December 21, 2018
Early Linguistic Markers of Trauma-Specific Processing Predict Post-trauma AdjustmentBirgit Kleim, Andrea B Horn, Rainer Kraehenmann, et al.
Frontiers in Psychology|August 23, 2018
Too Imperfect to Fall Asleep: Perfectionism, Pre-sleep Counterfactual Processing, and InsomniaRalph E Schmidt, Delphine S Courvoisier, Stéphane Cullati, et al.
Human Brain Mapping|February 27, 2016
Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulationMilan Scheidegger, Anke Henning, Martin Walter, et al.
Neuroimage|July 17, 2017
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flowCandace R Lewis, Katrin H Preller, Rainer Kraehenmann, et al.
Neuroimage. Clinical|February 25, 2016
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivityRainer Kraehenmann, André Schmidt, Karl Friston, et al.
Pageof 3